L-156,602 (Synonyms: PD 124966) |
| Catalog No.GC18900 |
L-156,602 is an antagonist of the complement component 5A (C5a) receptor (IC50 = 1.7 ug/L in a radioligand binding assay using neutrophil membranes).
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 125228-51-5
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
L-156,602 is an antagonist of the complement component 5A (C5a) receptor (IC50 = 1.7 ug/L in a radioligand binding assay using neutrophil membranes). It is also a cyclic depsipeptide antibiotic that is active against Gram-positive bacteria. L-156,602 has anti-inflammatory activity in mice, decreasing inflammation induced by muramyl dipeptide (MDP) when administered at a dose of 0.5 mg/kg and by concanavalin A at doses of 0.25 and 0.5 mg/kg.
Review for L-156,602
Average Rating: 5 (Based on Reviews and 10 reference(s) in Google Scholar.)
Review for L-156,602
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *